A detailed history of Legal & General Group PLC transactions in Baxter International Inc stock. As of the latest transaction made, Legal & General Group PLC holds 3,936,971 shares of BAX stock, worth $116 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,936,971
Previous 3,936,971 -0.0%
Holding current value
$116 Million
Previous $149 Million -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.85 - $40.26 $3.99 Million - $4.89 Million
121,470 Added 3.18%
3,936,971 $149 Million
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $1.47 Million - $1.95 Million
44,789 Added 1.19%
3,815,501 $128 Million
Q1 2024

Jul 01, 2024

BUY
$37.88 - $43.77 $2.1 Million - $2.42 Million
55,368 Added 1.49%
3,770,712 $161 Million
Q1 2024

May 14, 2024

SELL
$37.88 - $43.77 $4.37 Million - $5.06 Million
-115,496 Reduced 3.01%
3,715,344 $159 Million
Q4 2023

Feb 15, 2024

BUY
$31.71 - $38.95 $14.6 Million - $18 Million
460,970 Added 13.68%
3,830,840 $148 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $5.13 Million - $6.78 Million
-137,505 Reduced 3.92%
3,369,870 $127 Million
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $547,206 - $652,596
13,687 Added 0.39%
3,507,375 $160 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $1.07 Million - $1.49 Million
28,434 Added 0.82%
3,493,688 $142 Million
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $7.81 Million - $9.07 Million
-157,146 Reduced 4.34%
3,465,254 $177 Million
Q3 2022

Nov 14, 2022

SELL
$53.86 - $66.8 $6.99 Million - $8.67 Million
-129,800 Reduced 3.46%
3,622,400 $195 Million
Q2 2022

Aug 22, 2022

SELL
$63.83 - $80.0 $35.1 Million - $44 Million
-549,661 Reduced 12.78%
3,752,200 $241 Million
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $15 Million - $17.5 Million
195,472 Added 4.76%
4,301,861 $334 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $9.72 Million - $11.4 Million
-130,327 Reduced 3.08%
4,106,389 $352 Million
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $10.4 Million - $11.8 Million
141,387 Added 3.45%
4,236,716 $341 Million
Q2 2021

Aug 12, 2021

BUY
$80.5 - $88.01 $22.3 Million - $24.4 Million
277,415 Added 7.27%
4,095,329 $330 Million
Q1 2021

May 17, 2021

SELL
$76.38 - $86.03 $1.78 Million - $2 Million
-23,304 Reduced 0.61%
3,817,914 $322 Million
Q4 2020

Feb 12, 2021

BUY
$75.39 - $82.36 $1.39 Million - $1.52 Million
18,414 Added 0.48%
3,841,218 $308 Million
Q3 2020

Nov 13, 2020

BUY
$78.33 - $90.73 $270,316 - $313,109
3,451 Added 0.09%
3,822,804 $307 Million
Q2 2020

Aug 14, 2020

BUY
$78.66 - $94.14 $6.31 Million - $7.55 Million
80,198 Added 2.14%
3,819,353 $329 Million
Q1 2020

May 14, 2020

BUY
$71.57 - $93.3 $10.8 Million - $14 Million
150,423 Added 4.19%
3,739,155 $304 Million
Q4 2019

Feb 13, 2020

BUY
$76.7 - $88.45 $5.83 Million - $6.73 Million
76,044 Added 2.16%
3,588,732 $300 Million
Q3 2019

Nov 13, 2019

BUY
$81.4 - $89.78 $4.22 Million - $4.66 Million
51,886 Added 1.5%
3,512,688 $307 Million
Q2 2019

Aug 14, 2019

SELL
$73.44 - $82.41 $3.83 Million - $4.29 Million
-52,098 Reduced 1.48%
3,460,802 $283 Million
Q1 2019

May 15, 2019

BUY
$64.48 - $81.31 $37.9 Million - $47.8 Million
588,457 Added 20.12%
3,512,900 $286 Million
Q4 2018

Feb 15, 2019

BUY
$61.45 - $77.8 $16 Million - $20.2 Million
260,059 Added 9.76%
2,924,443 $192 Million
Q3 2018

Nov 20, 2018

SELL
$70.71 - $77.75 $122,893 - $135,129
-1,738 Reduced 0.07%
2,664,384 $205 Million
Q2 2018

Aug 10, 2018

SELL
$63.43 - $75.41 $11.2 Million - $13.3 Million
-176,350 Reduced 6.2%
2,666,122 $197 Million
Q1 2018

May 17, 2018

SELL
$62.56 - $72.26 $22.3 Million - $25.8 Million
-356,615 Reduced 11.15%
2,842,472 $185 Million
Q4 2017

Feb 13, 2018

BUY
$61.45 - $66.05 $197 Million - $211 Million
3,199,087
3,199,087 $207 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.